The company cautioned against attempting to draw firm conclusions from the data on remdesivir, which came from only 53 patients treated with the drug under compassionate use protocols. More definitive Phase III randomized trials are underway.

LEAVE A REPLY

Please enter your comment!
Please enter your name here